Catalent catalent.com


Catalent (NYSE:CTLT), aka Catalent Pharma Solutions, is a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products.

Catalent (NYSE:CTLT), aka Catalent Pharma Solutions, is a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products.

Company (IPO / Went public)

Phone: 732-537-6200

Fax:

14 Schoolhouse Road

Somerset, 08873
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Catalent $871.3M Jul 31, 2014
Quinnova Pharmaceuticals $33M Dec 16, 2013
Pacira Pharmaceuticals $111.3M Apr 13, 2012
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Catalent Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Multi phase soft gel capsules, apparatus and method thereof Jun 03, 2011 Dec 19, 2017 Patent
Fusion antibodies Mar 09, 2010 Jan 10, 2017 Patent
Pharmaceutical oral dosage form containing a synthetic oligosaccharide Dec 17, 2010 Feb 16, 2016 Patent
Apparatus and method for filling containers Sep 19, 2008 Dec 17, 2013 Patent
Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme q10 Jun 01, 2005 Aug 28, 2012 Patent
See all 11 patents